We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

CEVEC Raises €6M to Grow CAP® Technology Based Protein and Vaccine Business

News   Aug 09, 2011

 
CEVEC Raises €6M to Grow CAP® Technology Based Protein and Vaccine Business
 
 
Advertisement
 

RELATED ARTICLES

Phase 1 Clinical Trial of University of Queensland COVID-19 Vaccine Begins

News

The first participants were enrolled into a Phase 1 clinical trial of the University of Queensland’s (UQ) COVID-19 vaccine candidate on July 13.

READ MORE

Creating an Artificial Energy Source To Power Muscles

News

A new study in the Biophysical Journal outlines the work of scientists who have created a series of compounds that could serve as an alternative synthetic energy source for myosin.

READ MORE

Twin Study Explores Genetic Tendency To Eat High or Low Fat Foods

News

New research has found that the tendency to like fatty food is more complex than its fat content alone – it could also be related to genetic traits related to fat perception.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE